HealthStream, Inc. HSTM
31.67 USD -2.91 (-8.42%)
At closeNov 3, 2026, 4:32 PM EST
31.67 0.00 0.00%
After hours · Nov 3, 4:32 PM ET
31.50 Day range 35.44
19.50 52-week range 35.61
- YTD
- +37.28%
- 1 year
- +25.08%
Analyst view
Consensus: buy
Buy
Price target (mean) 35.00 +10.5% upside
Now 31.67
- Target (low)
- 29.00
- Target (mean)
- 35.00
- Target (high)
- 40.00
Ratings (0m) 6 2 buy · 4 hold · 0 sell
- Strong buy0
- Buy2
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.145 | 0.14 – 0.15 | 0.20 | -27.5% | 82.16M | +7.4% | 2 |
| Next quarter | 0.15 | 0.15 – 0.15 | 0.18 | -16.7% | 82.86M | +4.0% | 2 |
| Current year | 0.73 | 0.73 – 0.73 | 0.70 | +4.3% | 329.45M | +8.4% | 1 |
| Next year | 0.885 | 0.84 – 0.93 | 0.73 | +21.2% | 344.58M | +4.6% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Freedom Capital Markets | Initiated | — | Hold |
| Jul 21, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| May 6, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Dec 17, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| Aug 7, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| May 15, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| Feb 26, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| Feb 6, 2025 | JMP Securities | Reiterated | Market Perform | Market Perform |
| Oct 23, 2024 | Barclays | Maintained | Overweight | Overweight |
| Oct 23, 2024 | Canaccord Genuity | Maintained | Hold | Hold |
| Jul 24, 2024 | Canaccord Genuity | Maintained | Hold | Hold |
| Dec 6, 2023 | JMP Securities | Initiated | — | Market Perform |
| Feb 22, 2023 | Canaccord Genuity | Maintained | — | Hold |
| Apr 28, 2021 | Canaccord Genuity | Maintained | — | Hold |
| Oct 28, 2020 | Canaccord Genuity | Maintained | — | Hold |
| Dec 20, 2019 | Raymond James | Initiated | — | Market Perform |
| Jul 11, 2018 | Barrington Research | Downgrade | Outperform | Market Perform |
| Jun 14, 2018 | Baird | Downgrade | Outperform | Neutral |
| Oct 25, 2017 | Baird | Maintained | — | Outperform |
| Oct 25, 2017 | Needham | Downgrade | Buy | Hold |
| Jul 26, 2017 | First Analysis | Upgrade | Underweight | Equal-Weight |
| Jan 23, 2017 | First Analysis | Downgrade | Equal-Weight | Underweight |
| Dec 2, 2016 | Baird | Upgrade | Neutral | Outperform |
| Nov 4, 2016 | Craig-Hallum | Downgrade | Buy | Hold |
| Nov 4, 2016 | Canaccord Genuity | Downgrade | Buy | Hold |
| Jul 27, 2016 | First Analysis | Downgrade | Overweight | Equal-Weight |
| Jun 29, 2016 | Barrington Research | Initiated | — | Outperform |
| Mar 29, 2016 | FBR Capital | Initiated | — | Outperform |
| Feb 17, 2016 | Needham | Upgrade | Hold | Buy |
| Aug 3, 2015 | Raymond James | Initiated | — | Market Perform |